Hyperlipidemia hypertension management

Prazosin may be particularly useful when patients cannot tolerate other types of antihypertensive agents or when blood pressure is not well controlled by other drugs. Since prazosin does not significantly influence blood uric acid or glucose levels, it can be used in hypertensive patients whose condition is complicated by gout or diabetes meUitus. Prazosin treatment is associated with favorable effects on plasma lipids. Thus, it may be of particular importance in managing patients with hyperlipidemia. 

The major steps in the management of patients with chronic heart failure are outlined in Table 13-3. The ACC/AHA 2005 guidelines suggest that treatment of patients at high risk (stages A and B) should be focused on control of hypertension, hyperlipidemia, and diabetes, if present. Once symptoms and signs of failure are present, stage C has been entered, and active treatment of failure must be initiated. 

Rubba, P. and lannuzzi. A., 2001, n-3 to n-6 fatty acids for managing hyperlipidemia, diabetes, hypertension and atherosclerosis is there evidence , 1103, 407. 

Short of revascularization, cessation of smoking is the single most important factor in the management of patients with intermittent claudication (55). In fact, in up to 85% of patients, walking distance can increase as much as 200 to 300% (56,57). Detection and treatment of hypertension and control of risk factors for cardiovascular disease such as smoking, diabetes, and hyperlipidemia offer substantial stroke prevention benefits as well. 

---